NDC 0591-3509 – Clonidine transdermal system
Clonidine .2 mg/d · Patch · Transdermal
Product NDC0591-3509
Product details
- Brand name
- Clonidine transdermal system
- Generic name
- Clonidine
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- Patch
- Route
- Transdermal
- Marketing category
- ANDA · ANDA090873
- Marketed since
- May 6, 2014
- Listing expires
- December 31, 2026
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Active ingredients
- Clonidine .2 mg/d
Uses, dosage, side effects and warnings for Clonidine transdermal system →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0591-3509-04 | 4 POUCH in 1 CARTON (0591-3509-04) / 1 PATCH in 1 POUCH (0591-3509-54) / 7 d in 1 PATCH | May 6, 2014 |
Recalls mentioning this NDC
- D-0472-2026 Apr 15, 2026 · Class II
CGMP Deviations: use of an unapproved raw material - D-0474-2026 Apr 15, 2026 · Class II
CGMP Deviations: use of an unapproved raw material - D-0473-2026 Apr 15, 2026 · Class II
CGMP Deviations: use of an unapproved raw material - D-0235-2022 Nov 24, 2021 · Class III
Failed Impurities/Degradation Specifications